0.3599
price up icon1.12%   0.004
 
loading
Biodesix Inc stock is traded at $0.3599, with a volume of 2.63M. It is up +1.12% in the last 24 hours and down -27.32% over the past month. Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.3559
Open:
$0.364
24h Volume:
2.63M
Relative Volume:
0.37
Market Cap:
$52.74M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-0.5537
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
+19.49%
1M Performance:
-27.32%
6M Performance:
-71.88%
1Y Performance:
-74.48%
1-Day Range:
Value
$0.34
$0.3679
1-Week Range:
Value
$0.2541
$0.5147
52-Week Range:
Value
$0.1718
$2.04

Biodesix Inc Stock (BDSX) Company Profile

Name
Name
Biodesix Inc
Name
Phone
303-417-0500
Name
Address
919 WEST DILLON ROAD, LOUISVILLE
Name
Employee
273
Name
Twitter
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
BDSX's Discussions on Twitter

Compare BDSX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
BDSX
Biodesix Inc
0.3599 32.24M 49.09M -52.15M -45.93M -0.65
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
393.08 152.86B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
184.12 136.66B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
499.08 41.18B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
107.83 32.05B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
135.99 24.29B 15.50B 1.33B 2.16B 7.34

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-14-25 Downgrade William Blair Outperform → Mkt Perform
Sep-16-24 Initiated Scotiabank Sector Outperform
Jul-26-24 Initiated Craig Hallum Buy
May-13-24 Initiated TD Cowen Buy
May-03-24 Initiated Lake Street Buy
Nov-17-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-23-20 Initiated BTIG Research Buy
Nov-23-20 Initiated Canaccord Genuity Buy
Nov-23-20 Initiated Morgan Stanley Overweight
Nov-23-20 Initiated William Blair Outperform
View All

Biodesix Inc Stock (BDSX) Latest News

pulisher
May 22, 2025

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting | BDSX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Biodesix to Present New Data on Host Immune Classifier for NSCLC at 2025 ASCO Annual Meeting - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Game-Changing Cancer Test Triples Survival Rate: New Clinical Data Transforms Lung Cancer Treatment - Stock Titan

May 22, 2025
pulisher
May 22, 2025

Biodesix (BDSX) Target Price Reduced to $2 by Scotiabank | BDSX Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut By Stocktwits - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Scotiabank cuts Biodesix stock target to $2, maintains outlook By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

Biodesix Approves Reverse Stock Split at Annual Meeting - TipRanks

May 21, 2025
pulisher
May 21, 2025

Scotiabank cuts Biodesix stock target to $2, maintains outlook - Investing.com

May 21, 2025
pulisher
May 21, 2025

Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX S - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Biodesix to Participate in Upcoming Investor Conferences | BDSX Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Biodesix to Participate in Upcoming Investor Conferences - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Biodesix Executives Set for Major Investor Conferences: William Blair and Craig-Hallum Presentations Ahead - Stock Titan

May 21, 2025
pulisher
May 20, 2025

Director’s Massive Stock Purchase Signals Confidence in Biodesix! - TipRanks

May 20, 2025
pulisher
May 19, 2025

Biodesix's (BDSX) "Market Perform" Rating Reaffirmed at William Blair - MarketBeat

May 19, 2025
pulisher
May 17, 2025

Craig Hallum Cuts Biodesix (NASDAQ:BDSX) Price Target to $1.50 - Defense World

May 17, 2025
pulisher
May 16, 2025

Biodesix revises 2025 revenue guidance to $80M–$85M amid sales force reconfiguration and primary care expansion - MSN

May 16, 2025
pulisher
May 16, 2025

Susquehanna International Group LLP Grows Stock Holdings in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat

May 16, 2025
pulisher
May 16, 2025

Biodesix, Inc. (NASDAQ:BDSX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Biodesix, Inc. Earnings Call: Growth Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025
pulisher
May 15, 2025

Analysts Just Slashed Their Biodesix, Inc. (NASDAQ:BDSX) EPS Numbers - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for Its Nodify Lung® Tests At ISPOR and ATS - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

News Flash: 6 Analysts Think Biodesix, Inc. (NASDAQ:BDSX) Earnings Are Under Threat - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS | BDSX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biodesix, Inc. to Present New Data on Lung Cancer Diagnosis and Testing at ISPOR and ATS 2025 Conferences - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

New Clinical Data: Biodesix Lung Cancer Tests Could Prevent 60% of Unnecessary Invasive Procedures - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award - GlobeNewswire

May 15, 2025
pulisher
May 14, 2025

Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 14, 2025
pulisher
May 14, 2025

Craig-Hallum Adjusts Price Target for Biodesix (BDSX) | BDSX Sto - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Diagnostic Leader Biodesix Clinches Elite Colorado Workplace Award, Employee Survey Reveals Why - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Biodesix stock plunges as life-sciences firm cuts sales projection - BizWest

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX): Analyst Maintains Buy Rating Despite Lowered Pr - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Lowered by Lake Street Analyst | BD - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Canaccord cuts Biodesix stock target to $1.50, keeps buy rating By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Biodesix stock target cut to $2 by TD Cowen, retains buy rating - Investing.com

May 14, 2025
pulisher
May 14, 2025

Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Lowered by Lake Street Analyst | BDSX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix Inc Reports Q1 2025 Earnings: EPS of -$0.08 Misses Esti - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix stock rating cut to Market Perform at William Blair By Investing.com - Investing.com South Africa

May 14, 2025
pulisher
May 14, 2025

BDSX: Canaccord Genuity Lowers Price Target for Biodesix | BDSX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Canaccord cuts Biodesix stock target to $1.50, keeps buy rating - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

BDSX Reports Q1 Revenue Below Expectations, Highlights Strategic - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $1.50 from $2.50 at Canaccord - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Price Target Reduced as 2025 Revenue Outlook Dec - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $1.50 from $3 at Craig-Hallum - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $2 from $3 at TD Cowen - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Downgraded to Market Perform by William Blair | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Reduced to $2 Amid Revenue Challeng - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Price Target Reduced as 2025 Revenue Outlook Declines | BDSX Stock News - GuruFocus

May 14, 2025

Biodesix Inc Stock (BDSX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$170.31
price up icon 0.43%
diagnostics_research LH
$241.22
price down icon 0.28%
diagnostics_research WAT
$341.79
price down icon 1.93%
$152.32
price down icon 0.02%
diagnostics_research MTD
$1,103.71
price down icon 2.74%
diagnostics_research IQV
$135.84
price down icon 1.65%
Cap:     |  Volume (24h):